Background Primary cutaneous B-cell lymphomas (PCBCLs) are frequently misdiagnosed, and a biopsy is needed to
Introduction
Primary cutaneous B-cell lymphomas (PCBCLs) are B-cell phenotype skin lymphomas that originate in the skin and have no extracutaneous disease at the time of diagnosis. PCBCLs are classified into three main types: primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL) and primary cutaneous diffuse large B-cell lymphoma -leg type (PCDLBCL-LT). While the first two types are recognized as indolent lymphomas, PCDLBCL-LT has a more aggressive behaviour 1 .
Classically, PCMZL is characterized by red to violaceous papules, plaques or nodules, frequently solitary, on the trunk or extremities in patients in their 50s; PCFCL presents as pink to violaceous papules or nodules, mainly on the head, in patients in their 60s; and PCDLBCL-LT typically presents as red to bluish infiltrated plaques, nodules or tumours on the lower extremities in elderly patients over 75 years old 2 . PCBCLs are frequently misdiagnosed as inflammatory and infectious lesions or as other cutaneous neoplasms.Recently, case reports 3, 4 and small case series 5 have suggested that dermoscopy may help to augment the clinical recognition of PCBCLs. We aimed to characterize the dermoscopic features of PCBCL, stratified by subtype and anatomic location to better appraise the role of dermoscopy in PCBCL diagnosis.
Methods
We performed a retrospective search for all patients with biopsyproven PCBCLs that were referred to Memorial Sloan Kettering Cancer Center (MSKCC) between the years 1992 and 2016. The study was approved by the Institutional Review Board. We identified 172 PCBCLs patients (99 PCMZL, 43 PCFCL, 30 PCDLBCL) for whom the initial diagnostic skin biopsy was reviewed at MSKCC and whose pathology report included the clinical differential diagnosis. For the dermoscopic evaluation, we retrospectively identified all PCBCLs lesions that were dermoscopically photographed prior to biopsy. Clinical and dermoscopic images were retrospectively retrieved from our imaging database (Vectra TM ,Canfield Imaging Systems, Fairfield, NJ, USA). We identified high-quality dermoscopic images of 58 PCBCL lesions from 51 patients. We excluded lesions with lowquality images (e.g. blur, over-exposure, excessive pressure resulting in skin blanching), and lesions that were imaged after biopsy had already been performed, to avoid confusion with scarring and inflammatory changes related to wound healing. Dermoscopic features evaluated for each lesion included colour, vessel morphology (as defined by Kittler et al. 6 ) and the presence of scale and ulceration. Two dermoscopy experts (A.S. and R.B.) who were blinded to the study objectives and diagnoses evaluated 17 dermoscopy images of PCBCL lesions with characteristic dermoscopic features and, for each lesion, chose their dermoscopic differential diagnosis from a given list. Relative frequencies were used to describe the differential diagnoses and dermoscopic features and were compared by PCBCL subtype and anatomic location using chi-squared test. All analyses were performed using IBM SPSS Statistics software (version 24).
Results
Analysing the clinical differential diagnosis in the pathology requisition slip for 172 newly diagnosed PCBCL biopsy-proven lesions, cutaneous lymphoma was suspected by the clinician in 28 cases (16.3%). Overall, skin malignancies were suspected in 94 lesions (54.7%); the leading diagnosis was basal cell carcinoma (BCC) in 30 cases (17.4%); other skin neoplasms including squamous cell carcinoma, dermatofibrosarcoma protuberans, cutaneous metastasis and melanoma were suspected less frequently. Non-neoplastic conditions were suspected in some cases, including cyst (21.5%), granulomatous processes (15.7%), and infectious disease (4.7%). The differential diagnosis by PCBCL subtype and anatomic site is shown (Table 1) . A low index of suspicion for skin lymphoma was seen regardless of PCBCL subtype and site; however, BCC was considered in the differential diagnosis significantly more frequently for PCFCL lesions (30.2%, P < 0.05) and in lesions arising on the head and neck regions (31.1%, P < 0.01).
We studied the dermoscopic images of 58 PCBCL lesions ( Table 2 , Fig. 1 ). All lesions were non-pigmented. Most lesions showed salmon-pink or yellow-to-orange-coloured background/ areas (n = 46, 79.3%) and prominent blood vessels (n = 45, 77.6%), with serpentine (linear-irregular) being the most frequently seen vascular morphology (n = 39, 67.2%). The combination of salmon colour and serpentine vessels was seen in 55% of all lesions while five cases showed neither (8.6%).
Two blinded dermoscopy experts evaluated the differential diagnosis, based on dermoscopic images alone, for 17 of the study lesions. They included CBCL in the differential diagnosis in 70.6% (12/17 lesions), while other common diagnoses mentioned by at least one of the experts were arthropod bite (58.8%), BCC (52.9%), amelanotic melanoma (47.1%) and scar/ keloid (47.1%). The experts disagreed on 29.9% of the suggested differential diagnoses.
Discussion
The presentation of cutaneous lymphomas in general and of PCBCLs in particular can be non-specific, and a biopsy is essential for a definitive diagnosis. In our study, skin lymphoma was clinically suspected in only 16.3% of PCBCL biopsy-proven lesions, while misdiagnosis as other skin malignancies, mainly BCC, was common.
Few studies evaluated the diagnostic value of dermoscopy in cutaneous lymphoma. Characteristic dermoscopic patterns of early-stage mycosis fungoides (MF) consisting of fine short linear vessels, and orange-yellowish patchy areas 7 or dotted vessels 8 were described. In lymphomatoid papulosis, a pattern of tortuous irregular vessels radiating from the centre was reported in early lesions 9 . The dermoscopic features that were reported for 10 PCBCL lesions included white circles, salmon-coloured background/area, scales, arborizing vessels or a polymorphous vascular pattern 5 . It was suggested that those dermoscopic features may improve the clinical recognition of PCBCLs 5 .
Studying the dermoscopic features in 58 PCBCL lesions, we identified in the majority of cases salmon-coloured background/ area and prominent blood vessels, most frequently serpentine vessels. Orange or salmon colour was previously reported in MF 7 and in PCBCL 5 ; this hue might be due to the dense dermal lymphocytic infiltrate along with the increased vascular flow in cutaneous lymphomas. The increased vascularity in PCBCL is attributed to the angiogenesis that accompanies the neoplastic process. 10 We found no significant differences in dermoscopic characteristics per subtype or anatomic location; other vascular morphologies, scaling and ulceration were rarely seen. PCBCL can present as subcutaneous nodules, and as expected, such deep-seated lesions display merely dull dermoscopic features, mostly homogeneous pink areas with no vessels. Although salmon-coloured background and serpentine vessels can suggest the diagnosis of CBCL, they are not specific and can raise a wide differential diagnosis of malignant and inflammatory conditions, as was demonstrated in the blinded evaluation by dermoscopy experts. Serpentine vessels are found in other skin malignancies, such as superficial BCC and melanoma. 6 Dermoscopic features should be evaluated cautiously to avoid overlooking other skin malignancies in PCBCL patients, such as collision between PCFCL and BCC 4 .While dermoscopy offers a bridge between the naked eye examination and the histopathological appearance, cutaneous lymphoma is diagnosed on a cellular level using histopathology, immunohistochemistry and molecular studies. Therefore, dermoscopy may serve as an ancillary tool in PCBCL; however, it cannot be diagnostic.
In conclusion, salmon-coloured area/background and serpentine vessels are frequently-seen dermoscopic features of PCBCL. Recognizing these dermoscopic features can assist in the initial diagnosis of PCBCL and in assessment of PCBCL recurrence. Primary cutaneous B-cell lymphoma dermoscopy However, these dermoscopic findings are not specific and should be integrated with the clinical findings. 
